Cell Signaling Technology Logo
1% for the planet logo
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

LYPLAL1 (F3Z9O) Rabbit mAb #34367

Filter:
  • WB
  • IP

    Supporting Data

    REACTIVITY H
    SENSITIVITY Endogenous
    MW (kDa) 26
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    • IP-Immunoprecipitation 
    Species Cross-Reactivity Key:
    • H-Human 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000
    Immunoprecipitation 1:50

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    LYPLAL1 (F3Z9O) Rabbit mAb recognizes endogenous levels of total LYPLAL1 protein.

    Species Reactivity:

    Human

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Gly72 of human LYPLAL1 protein.

    Background

    Lysophospholipase-like 1 (LYPLAL1) is a serine hydrolase that has been linked to various metabolic disorders, including insulin resistance and non-alcoholic fatty liver disease (1,2). Although it is evolutionarily conserved, knockout studies in mice confirm that LYPLAL1 is not essential for normal metabolic function (3). LYPLAL1 has also been shown to depalmitoylate cyclic GMP-AMP synthase (cGAS), inhibiting cGAS enzymatic activity and downstream signaling (4). Inhibition of LYPLAL1 results in enhanced cGAS-mediated innate immune signaling, suggesting that this treatment could be used to bolster anti-tumor immunotherapies such as PD-1 blockade (4).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.